LIQUID VACCINES OF LIVE ENVELOPED VIRUSES

The present invention describes a liquid vaccine composition of a live enveloped virus and a pharmaceutically acceptable carrier, whereby the carrier is a natural deep-eutectic solvent (NADES), and the vaccine has a water activity of less than about 0.8. The NADES provides a stabilisation of the sen...

Full description

Saved in:
Bibliographic Details
Main Authors Kets, Edwin, Dirks, Chris, Piest, Martin, Vermeij, Paul
Format Patent
LanguageEnglish
Published 26.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention describes a liquid vaccine composition of a live enveloped virus and a pharmaceutically acceptable carrier, whereby the carrier is a natural deep-eutectic solvent (NADES), and the vaccine has a water activity of less than about 0.8. The NADES provides a stabilisation of the sensitive virus for prolonged time and at ambient temperature. In general, the liquid vaccine compositions according to the invention, in different compositions for the various enveloped viruses, show remarkable capabilities of stabilisation. This overcomes the need for lyophilisation, a great economic benefit. Also the liquid nature of the vaccines facilitates administration to human or animal targets.
AbstractList The present invention describes a liquid vaccine composition of a live enveloped virus and a pharmaceutically acceptable carrier, whereby the carrier is a natural deep-eutectic solvent (NADES), and the vaccine has a water activity of less than about 0.8. The NADES provides a stabilisation of the sensitive virus for prolonged time and at ambient temperature. In general, the liquid vaccine compositions according to the invention, in different compositions for the various enveloped viruses, show remarkable capabilities of stabilisation. This overcomes the need for lyophilisation, a great economic benefit. Also the liquid nature of the vaccines facilitates administration to human or animal targets.
Author Piest, Martin
Vermeij, Paul
Kets, Edwin
Dirks, Chris
Author_xml – fullname: Kets, Edwin
– fullname: Dirks, Chris
– fullname: Piest, Martin
– fullname: Vermeij, Paul
BookMark eNrjYmDJy89L5WTQ9PEMDPV0UQhzdHb29HMNVvB3U_DxDHNVcPULc_XxD3AFSnkGhQa7BvMwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDIwNjMwtjEzNHQ2PiVAEArnQnEg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2020368346A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2020368346A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:08:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2020368346A13
Notes Application Number: US201816769820
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201126&DB=EPODOC&CC=US&NR=2020368346A1
ParticipantIDs epo_espacenet_US2020368346A1
PublicationCentury 2000
PublicationDate 20201126
PublicationDateYYYYMMDD 2020-11-26
PublicationDate_xml – month: 11
  year: 2020
  text: 20201126
  day: 26
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Intervet Inc
RelatedCompanies_xml – name: Intervet Inc
Score 3.2915015
Snippet The present invention describes a liquid vaccine composition of a live enveloped virus and a pharmaceutically acceptable carrier, whereby the carrier is a...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title LIQUID VACCINES OF LIVE ENVELOPED VIRUSES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201126&DB=EPODOC&locale=&CC=US&NR=2020368346A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkEp-FDs-pG1D0W2NGWVrZ3bWvY20g9BkDlcxX_fS-h0T3tLcnD5gPtK8rsDeECPmnft3NVct1dolsNzjRtdrmW2qecmShiX-IpxRIaJ9bKwFw342GJhZJ7QH5kcESUqR3mvpL5e_19i-fJv5eYpe8ehz-dg7vlqHR0La2YQ1R94bBL7MVUp9ZKZGk0lzSSOaZE-xkoHwpEWmfZZOhC4lPWuUQlO4XCC_FbVGTTKVQuO6bb2WguOxvWTNzZr6ducw-MofE1CX0n7lIpiGUocKKMwZQqLZCVNhqRwmqCGvID7gM3pUMM5l39bXCaz3QWal9DE4L-8AqUQGbR6dukaJbcsnTuc6y433gzCuwXhdhs6-zhd7yffwInoCmydQTrQrL6-y1s0slV2J8_mF1bqeo4
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakAJeAjmuU0ORdpNQqNpWtsm9BY2D0GQWmzEv-_skmpPvS07MPuAb2Znd78ZgHs8UTPNyh3FcbqFYtosV5iuMSWzDDU3EGFM8CtGERnG5vPCWjTgY8OFEXlCf0RyRERUjnivhL1e_V9iueJv5foxe8euzyd_3nPlOjrm3kwnsjvoeZOxO6Yypb14JkdTITOIbZikj7HSXpfn5-WHp2TAeSmrbafiH8H-BPUtq2NolMs2tOim9lobDkb1kzc2a_StT-AhDF7jwJWSPqW8WIY09qUwSDzJi0QlTQ9FwTRGC3kKd743p0MFx0z_lpjGs-0JGmfQxOC_PAep4Bm0ulbp6CUzTZXZjKkO0990wrSCMOsCOrs0Xe4W30JrOB-FaRhEL1dwyEWcZ6eTDjSrr-_yGh1uld2IffoFOm19ew
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=LIQUID+VACCINES+OF+LIVE+ENVELOPED+VIRUSES&rft.inventor=Kets%2C+Edwin&rft.inventor=Dirks%2C+Chris&rft.inventor=Piest%2C+Martin&rft.inventor=Vermeij%2C+Paul&rft.date=2020-11-26&rft.externalDBID=A1&rft.externalDocID=US2020368346A1